POMERO FULVIO

Consigliere dell’Ordine del Medici Chirurghi e Odontoiatri della Provincia di Cuneo 

 DATI BIBLIOMETRICI:   H-index: 25

                                         Citazioni totali: 2148

PRODUZIONE SCIENTIFICA SU RIVISTE INTERNAZIONALI CON IMPACT FACTOR

1. Camerlo S, Radin M, Rosati G, Padrini M, Montaruli B, Russo I, Barale C, Barinotti A, Cecchi I, Galarza D, Pomero F, De Gobbi M, Sciascia S, Morotti A. Anti-Phosphatidylserine/Prothrombin Antibodies Identify a Distinct Form of ITP. EJHaem. 2025 Oct 4;6(5):e70154. doi: 10.1002/jha2.70154. Impact factor 1.1

2. Luzzati R, Zerbato V, Attard L, Virgili G, Cilli A, Zanier A, Libanore M, Segala D, Tedesco A, Bortolotti ME, Pontali E, Feasi M, Re A, Giarretta I, Pomero F, Zagarrì E, Concia E, Dentali F, Manfellotto D, Campanini M; FADOI-FUO Study Group.Fever of unknown origin (FUO) FADOI-SIMIT Italian registry: can demographics, comorbidities, and clinical variables predict the etiology of classic FUO?-a prospective Italian study. Intern Emerg Med. 2025 Aug 19. doi: 10.1007/s11739-025-04084-1. Impact factor 3.3

3. Grosso V, Bulai F, Cerato A, Olivero C, Praticò I, Galli E, Diana F, Nicoletto M, Grosso A, La Via L, Pomero F.The Role of Anti-MDA5 Antibodies in Rapidly Progressive Interstitial Lung Disease: A Case Report and Literature Review. Rev Recent Clin Trials. 2025 May 13. Impact Factor 1.3

4. Nicoletto M, Ferrannini G, Galli E, Grosso A, Camerlo S, Bulai F, Marchisio A, Pomero F.Direct oral anticoagulants vs vitamin K antagonists in patients with single- or double-positive antiphospholipid syndrome: a systematic review and meta-analysis. Pol Arch Intern Med. 2025 Jun 24;135(6):17006. doi: 10.20452/pamw.17006. Impact factor 3.2

5. Donadini MP, Mumoli N, Fenu P, Pomero F, Re R, Palmiero G, Spadafora L, Mazzi V, Grittini A, Bertù L, Aujesky D, Dentali F, Ageno W, Squizzato A. The Clinical Impact of the Pulmonary Embolism Severity Index on the Length of Hospital Stay of Patients with Pulmonary Embolism: A Randomized Controlled Trial. Diagnostics (Basel). 2024;14:776. Impact Factor: 3.0

6. Becattini C, Cimini LA, Bassanelli G, Maggioni AP, Pomero F, Lobascio I, Enea I, Pomata DP, Ruggieri MP, Zalunardo B, Novelli A, Di Fusco SA, Triggiani M, Marzolo M, Fioravanti C, Agnelli G, Gonzini L, Gulizia MM; COPE Investigators. Correction: Acute pulmonary embolism and cancer: findings from the COPE study. Clin Res Cardiol. 2024;113:1280-1283. Impact Factor: 3.8

7. Becattini C, Cimini LA, Bassanelli G, Maggioni AP, Pomero F, Lobascio I, Enea I, Pomata DP, Ruggieri MP, Zalunardo B, Novelli A, Di Fusco SA, Triggiani M, Marzolo M, Fioravanti C, Agnelli G, Gonzini L, Gulizia MM; COPE Investigators. Acute pulmonary embolism and cancer: findings from the COPE study. Clin Res Cardiol. 2024;113:288-300. Impact Factor: 3.8

8.Pieralli F, Pomero F, Dentali F, Norbiato C, Attardo T, Vicari S, Magnani E, Marzilli MA, Piccolo P, Valerio A, Manfellotto D; FADOI RECOVER Study Group. Real-world use of remdesivir for the treatment of patients admitted to Italian hospitals with COVID-19: the nationwide retrospective FADOI-RECOVER study. BMC Infect Dis. 2023;23(1):454. Impact Factor: 3.4

9.Mastroiacovo D, Mengozzi A, Dentali F, Pomero F, Virdis A, Camerota A, Muselli M, Necozione S, Bocale R, Ferri C, Desideri G. Enhanced Carotid Plaque Echolucency Is Associated with Reduced Cognitive Performance in Elderly Patients with Atherosclerotic Disease Independently on Metabolic Profile. Metabolites. 2023;13(4):478. Impact Factor: 4.0

10.Becattini C, Agnelli G, Maggioni AP, Dentali F, Fabbri A, Enea I, Pomero F, Ruggieri MP, di Lenarda A, Cimini LA, Pepe G, Cozzio S, Lucci D, Gulizia MM; COPE Investigators. Contemporary Management and Clinical Course of Acute Pulmonary Embolism: The COPE Study. Thromb Haemost. 2023;123(6):613-626. Impact Factor: 5.5

11.Pieralli F, Pomero F, Corbo L, Fortini A, Guazzini G, Lastraioli L, Luise F, Mancini A, Maddaluni L, Milia A, Sammicheli L, Mani F, Marcucci R. Incidence of lower limb deep vein thrombosis in patients with COVID-19 pneumonia through different waves of SARS-CoV-2 pandemic: A multicenter prospective study. PLoS One. 2023;18(2):e0280247. Impact Factor: 2.9

12.Ageno W, Bertù L, Bucherini E, Camporese G, Dentali F, Iotti M, Lessiani G, Parisi R, Prandoni P, Sartori M, Visonà A, Bigagli E, Palareti G; RIDTS study group. Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ. 2022;379:e072623. Impact Factor: 93.7

13.Manzini PM, Ciccone G, De Rosa FG, Cavallo R, Ghisetti V, D’Antico S, Galassi C, Saccona F, Castiglione A, Birocco N, Francisci T, Hu H, Pecoraro C, Danielle F, Labanca L, Bordiga AM, Lorenzi M, Camisasca G, Giachino O, Pagliarino M, Ottone P, Scuvera ITD, Guaschino R, Freilone R, Berti P, Pittaluga F, Avolio M, Costa C, Raso S, Nucci A, Milan M, Baffa A, Russo A, Tornello A, Maddalena L, Delios G, Marletto FP, De Micheli AG, Mattei A, Baldassano S, Canta F, Russo ML, Bergamo D, Vitale F, Liccardi MM, Chinaglia A, Calcagno A, Converso M, Aldieri C, Libanore V, Blangetti I, Benedetti V, Mitola B, Scozzari G; PLACO COVID Study Group. Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial. BMC Infect Dis. 2022 Nov 22;22(1):879. Impact Factor: 3.4

14.Pomero F, Dentali F, Nicoletto M, Spadafora L, Mumoli N, Mastroiacovo D. Association between inherited thrombophilia and venous thromboembolism in patients with non-O blood type: a meta-analysis. Pol Arch Intern Med. 2022;132(12):16327. Impact Factor: 4.8

15.Galli E, Maggio E, Pomero F. Venous Thromboembolism in Sepsis: From Bench to Bedside. Biomedicines. 2022 Jul 8;10(7):1651. Impact Factor: 3.9

16.Bikdeli B, Caraballo C, Trujillo-Santos J, Galanaud JP, di Micco P, Rosa V, Cusidó GV, Schellong S, Mellado M, Del Valle Morales M, Gavín-Sebastián O, Mazzolai L, Krumholz HM, Monreal M; RIETE Investigators. Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry. JAMA Cardiol. 2022;7(8):857-865. Impact Factor: 2.4

17.Ageno W, Beyer Westendorf J, Contino L, Bucherini E, Sartori MT, Senzolo M, Grandone E, Santoro R, Carrier M, Delluc A, De Stefano V, Pomero F, Donadini MP, Tosetto A, Becattini C, Martinelli I, Nardo B, Bertoletti L, Di Nisio M, Lazo-Langner A, Schenone A, Riva N. Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study. Blood Adv. 2022 Jun 28;6(12):3569-3578. Impact Factor: 7.4

18.Gilardi E, Pomero F, Ravera E, Piccioni A, Santoro MC, Bonadia N, Carnicelli A, Di Maurizio L, Sabia L, Longhitano Y, Saviano A, Ojetti V, Savioli G, Zanza C, Franceschi F. Intravenous Magnesium Sulfate Reduces the Need for Antiarrhythmics during Acute-Onset Atrial Fibrillation in Emergency and Critical Care. J Clin Med. 2022 Sep 21;11(19):5527. Impact Factor: 3.0

19.Pomero F, Galli E, Bellesini M, Maroni L, Squizzato A. P2Y12 inhibitors plus aspirin for acute treatment and secondary prevention in minor stroke and high-risk transient ischemic attack: A systematic review and meta-analysis. Eur J Intern Med. 2022 Mar 21;S0953-6205(22)00106-6. doi:10.1016/j.ejim.2022.03.017. Impact Factor: 4.329

20.Pomero F, Dentali F, Squizzato A, Bonzini M, Guasti L. Diagnostic performance of D-dimer for upper extremity deep vein thrombosis: A systematic review and meta-analysis. Semin Thromb Hemost. 2022;48(1):96–102. doi:10.1055/s-0041-1736334. Impact Factor: 3.709

21.Visonà A, Pomero F, Marzaro G, Camporese G. Upper extremity deep vein thrombosis: Indications for anticoagulant treatment and duration. A systematic review. Eur J Intern Med. 2022;103:40–46. doi:10.1016/j.ejim.2022.06.006. Impact Factor: 4.329

22.Pomero F, Marzaro G, Camporese G, Visonà A. Direct oral anticoagulants in upper extremity deep vein thrombosis: a systematic review. Expert Rev Hematol. 2022;15(1):47–55. oi:10.1080/17474086.2022.2027913. Impact Factor: 2.4

23.Pomero F, Squizzato A. D-dimer testing in pregnancy. Expert Rev Hematol. 2021;14(1):7–17. doi:10.1080/17474086.2021.1866545. Impact Factor: 2.4

24.Pomero F, Dentali F, Borretta V, Camporese G. Diagnostic performance of ultrasonography in patients with suspected upper extremity deep vein thrombosis: a systematic review and meta-analysis. Thromb Res. 2020;196:428–437. doi:10.1016/j.thromres.2020.10.034. Impact Factor: 4.034

25.Pomero F, Dentali F, Borretta V, Camporese G. Prognostic role of residual thrombosis in upper extremity deep vein thrombosis: a systematic review and meta-analysis. Thromb Res. 2021;198:82–88. doi:10.1016/j.thromres.2020.12.013. Impact Factor: 4.034

26.Pomero F, Dentali F, Camporese G. Direct oral anticoagulants for the treatment of upper extremity deep vein thrombosis: a systematic review. Curr Vasc Pharmacol. 2021;19(3):317–324. doi:10.2174/1570161118666200601112604. Impact Factor: 2.264

27.Pomero F, Marzaro G, Camporese G, Visonà A. Management of catheter-related thrombosis in cancer patients: a systematic review. Thromb Res. 2020;191:27–34. doi:10.1016/j.thromres.2020.04.019. Impact Factor: 4.034

28.Dentali F, Pomero F, Camporese G. Direct oral anticoagulants for the treatment of cancer-related venous thromboembolism: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost. 2019;17(9):1476–1485. doi:10.1111/jth.14582. Impact Factor: 6.942

29.Pomero F, Dentali F, Borretta V, Camporese G. Incidence of post-thrombotic syndrome after upper extremity deep vein thrombosis: a systematic review and meta-analysis. Thromb Haemost. 2018;118(10):1851–1860. doi:10.1055/s-0038-1673357. Impact Factor: 4.952

30.Camporese G, Bernardi E, Prandoni P, Noventa F, Verlato F, Andreozzi GM, et al. Low-molecular-weight heparin versus oral anticoagulant therapy for symptomatic catheter-related upper extremity deep vein thrombosis in cancer patients: A randomized trial. Ann Intern Med. 2018;169(7):472–482. doi:10.7326/M18-0184. Impact Factor: 25.391

31.Pomero F, Dentali F, Camporese G. Upper extremity deep vein thrombosis: risk factors, diagnosis, and management. Vasc Med. 2015;20(2):113–124. doi:10.1177/1358863X14568244. Impact Factor: 2.499

32.Camporese G, Bernardi E, Noventa F, Verlato F, Simioni P, Prandoni P. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and management. Thromb Haemost. 2008;99(6):1097–1105. doi:10.1160/TH08-01-0059. Impact Factor: 4.952

33.Camporese G, Bernardi E, Prandoni P, Noventa F, Verlato F, Simioni P, et al. A randomized study of anticoagulation vs. elastic bandaging for the treatment of superficial vein thrombosis of the upper extremities. J Thromb Haemost. 2012;10(6):1093–1099. doi:10.1111/j.1538-7836.2012.04734.x. Impact Factor: 6.942

34.Camporese G, Bernardi E, Prandoni P, Noventa F, Verlato F, Simioni P, et al. The PROSPER study: Prospective observation on upper extremity superficial vein thrombosis. J Thromb Haemost. 2011;9(6):1220–1226. doi:10.1111/j.1538-7836.2011.04296.x. Impact Factor: 6.942

35.Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M; Caravaggio Investigators. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Impact factor: 72.406

36.Badinella Martini M, Dentali F, Pizzini A, D’Ascenzo F, Fenoglio L, Pomero F. The prophylaxis of venous thromboembolism in medical outpatients: results of a survey among Italian general practitioners. Acta Biomed. 2020 Mar 19;91(1):7-14. doi: 10.23750/abm.v91i1.8275.

37.Franco L, Paciaroni M, Enrico ML, Scoditti U, Guideri F, Chiti A, De Vito A, Terruso V, Consoli D, Vanni S, Giossi A, Manina G, Nitti C, Re R, Sacco S, Cappelli R, Beyer-Westendorf J, Pomero F, Agnelli G, Becattini C. Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy. Eur J Intern Med. 2020 May;75:35-43. doi: 10.1016/j.ejim.2019.12.016. Epub 2020 Jan 16. Impact factor: 3.660

38.Pomero F, Ageno W, Dentali F, Fenoglio L, Squizzato A, Bonzini M. Vena Cava Filters and In-Hospital Case Fatality Among Patients With Pulmonary Embolism: Results From a Large Population-Based Study. Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619888022. doi: 10.1177/1076029619888022. Impact factor: 1.846

39.Pomero F, Dentali F, Mumoli N, Salomone P, Tangianu F, Desideri G, Mastroiacovo D. The continuous challenge of antithrombotic strategies in diabetes: focus on direct oral anticoagulants. Acta Diabetol. 2019 Dec;56(12):1247-1258. doi: 10.1007/s00592-019-01426-2. Epub 2019 Sep 24. Impact factor: 2.996

40.Pomero F, Spadafora L, D’Agnano S, Dentali F, Fenoglio LM. Direct oral anticoagulants in factor VII deficiency patient. Intern Emerg Med. 2019 Nov;14(8):1353-1356. doi: 10.1007/s11739-019-02186-1. Impact factor: 2.223

41.Riera-Mestre A, Mora-Luján JM, Trujillo-Santos J, Del Toro J, Nieto JA, Pedrajas JM, López-Reyes R, Soler S, Ballaz A, Cerdà P, Monreal M; RIETE Investigators. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry. Orphanet J Rare Dis. 2019 Aug 9;14(1):196. doi: 10.1186/s13023-019-1172-8. Impact factor: 3.687

42.Rezoagli E, Barzaghi N, Crowther M, Dentali F, Pomero F. Antiphospholipid Syndrome During Septic Shock: Hyper- or Hypocoagulability?: A Case Report. A A Pract. 2019 Oct 15;13(8):306-309. doi: 10.1213/XAA.0000000000001061.

43.Imberti D, Pomero F, Mastroiacovo D. Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study. Blood Transfus. 2020 Jan;18(1):49-57. doi: 10.2450/2019.0265-18. Impact factor: 3.352

44.Mumoli N, Mastroiacovo D, Giorgi-Pierfranceschi M, Pesavento R, Mochi M, Cei M, Pomero F, Mazzone A, Vitale J, Ageno W, Dentali F. Ultrasound elastography is useful to distinguish acute and chronic deep vein thrombosis. J Thromb Haemost. 2018 Dec;16(12):2482-2491. doi: 10.1111/jth.14297. Impact factor: 5.287

45.Dentali F, Barco S, Pegoraro S, Di Minno MND, Mastroiacovo D, Pomero F, Lodigiani C, Bagna F, Sartori M, Barillari G, Mumoli N, Napolitano M, Passamonti SM, Benedetti R, Ageno W, Di Nisio M. Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer. J Thromb Thrombolysis. 2018 Oct;46(3):404-408. doi: 10.1007/s11239-018-1708-0. Impact factor: 2.941

46.Serraino C, Elia C, Bracco C, Rinaldi G, Pomero F, Silvestri A, Melchio R, Fenoglio LM. Characteristics and management of pyogenic liver abscess: A European experience. Medicine (Baltimore). 2018;97:e0628. doi: 10.1097/MD.0000000000010628. Impact factor: 1.803

47.Franco L, Becattini C, Vanni S, Sbrojavacca R, Nitti C, Manina G, Masotti L, Pomero F, Cattinelli S, Cappelli R, Re R, Agnelli G. Clinically relevant non-major bleeding with oral anticoagulants: non-major may not be trivial. Blood Transfus. 2017 Mar 15:1-5. doi: 10.2450/2017.0335-16. Impact factor: 1.607

48.Donadini MP, Dentali F, Pegoraro S, Pomero F, Brignone C, Guasti L, Steidl L, Ageno W. Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study. Vascular Medicine. 2017;22:518-524. doi: 10.1177/1358863X17720531. Impact factor: 1.866

49.Becattini C, Franco L, Beyer-Westendorf J, Masotti L, Nitti C, Vanni S, Manina G, Cattinelli S, Cappelli R, Sbrojavacca R, Pomero F, Marten S, Agnelli G. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life. International Journal of Cardiology. 2017;227:261-266. doi: 10.1016/j.ijcard.2016.11.117. Impact factor: 6.189

50.Ageno W, Dentali F, Pomero F, Fenoglio L, Squizzato A, Pagani G, Re R, Bonzini M. Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome. Thrombosis and Haemostasis. 2017;117:794-800. doi: 10.1160/TH16-10-0781. Impact factor: 5.627

51.Squizzato A, Pomero F, Allione A, Priotto R, Riva N, Huisman MV, Klok FA, Stein PD, Guasti L, Fenoglio L, Dentali F, Ageno W. Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis. Thrombosis Research. 2017;154:64-72. doi: 10.1016/j.thromres.2017.03.027. Impact factor: 2.650

52.Donadini MP, Dentali F, Castellaneta M, Gnerre P, La Regina M, Masotti L, Pieralli F, Pomero F, Re R, Guasti L, Ageno W, Squizzato A. Pulmonary embolism prognostic factors and length of hospital stay: A cohort study. Thrombosis Research. 2017;156:155-159. doi: 10.1016/j.thromres.2017.06.009. Impact factor: 2.650

53.Dentali F, Pegoraro S, Barco S, Di Minno MND, Mastroiacovo D, Pomero F, Lodigiani C, Bagna F, Sartori M, Barillari G, Mumoli N, Napolitano M, Passamonti SM, Benedetti R, Ageno W, Di Nisio M. Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study. Journal of Thrombosis and Haemostasis. 2017;15:1757-1763. doi: 10.1111/jth.13761. Impact factor: 5.287

54.Di Napoli M, Behrouz R, Topel CH, Misra V, Pomero F, Giraudo A, Pennati P, Masotti L, Schreuder FHBM, Staals J, Klijn CJM, Smith CJ, Parry-Jones AR, Slevin MA, Silver B, Willey JZ, Azarpazhooh MR, Vallejo JM, Nzwalo H, Popa-Wagner A, Godoy DA. Hypoalbuminemia, systemic inflammatory response syndrome, and functional outcome in intracerebral hemorrhage. Journal of Critical Care. 2017;41:247-253. doi: 10.1016/j.jcrc.2017.06.002. Impact factor: 2.648

55.Barco S, Pomero F, Di Minno MND, Permunian ET, Malato A, Pasca S, Barillari G, Fenoglio L, Siragusa S, Di Minno G, Ageno W, Dentali F. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study. Journal of Thrombosis and Haemostasis. 2017;15:2176-2183. doi: 10.1111/jth.13840. Impact factor: 5.287

56.Becattini C, Franco L, Masotti L, Nitti C, Cattinelli S, Cappelli R, Manina G, Sbrojavacca R, Pomero F, Agnelli G. Clinical management and outcome of major bleeding in patients on treatment with vitamin K antagonists. European Journal of Internal Medicine. 2016;33:47-54. doi: 10.1016/j.ejim.2016.05.019. Impact factor: 2.789

57.Dentali F, Crowther M, Galli M, Pomero F, Garcia D, Clark N, Spadafora L, Witt DM, Ageno W. Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature. Seminars in Thrombosis and Hemostasis. 2016;42:671-681. doi: 10.1055/s-0036-1581105. Impact factor: 3.629

58.Imberti D, Pomero F, Benedetti R, Fenoglio L. Safety and efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism. Internal and Emergency Medicine. 2016;11:895-900. doi: 10.1007/s11739-016-1521-8. Impact factor: 2.340

59.Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez AF, Gibson CM; APEX Investigators; Pomero F et al. Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients. New England Journal of Medicine. 2016;375:534-544. doi: 10.1056/NEJMoa1601747. Impact factor: 72.406

60.Dentali F, Ageno W, Pomero F, Fenoglio L, Squizzato A, Bonzini M. Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thrombosis and Haemostasis. 2016;115:399-405. doi: 10.1160/TH15-02-0172. Impact factor: 5.627

61.Bracco C, Serraino C, Pomero F, Testa E. Extensive screening for occult cancer in unprovoked venous thromboembolism: not so useful? Internal and Emergency Medicine. 2016;11:595-596. doi: 10.1007/s11739-016-1424-8. Impact factor: 2.340

62.Melchio R, Margaria F, Bracco C, Pomero F, Fenoglio LM. Respiratory failure in portal hypertension: at the heart of the matter. Internal and Emergency Medicine. 2016;11:721-722. doi: 10.1007/s11739-016-1413-y. Impact factor: 2.340

63.Pomero F, Di Minno MND, Fenoglio L, Gianni M, Ageno W, Dentali F. Is diabetes a hypercoagulable state? A critical appraisal. Acta Diabetologica. 2015;52:1007-1016. doi: 10.1007/s00592-015-0746-8. Impact factor: 3.340

64.Serraino C, Melchio R, Silvestri A, Borretta V, Pomero F, Fenoglio L. Hepatitis C-associated Osteosclerosis: A New Case with Long-term Follow-up and a Review of the Literature. Internal Medicine. 2015;54:777-783. doi: 10.2169/internalmedicine.54.3448. Impact factor: 0.910

65.Parry-Jones AR, Di Napoli M, Goldstein JN, Schreuder FHBM, Tetri S, Tatlisumak T, Yan B, van Nieuwenhuizen KM, Dequatre-Ponchelle N, Lee-Archer M, Horstmann S, Wilson D, Pomero F, Masotti L, Lerpinier, Staals J, Rosand J, Meretoja A. Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage. Annals of Neurology. 2015;78:54-62. doi: 10.1002/ana.24416. Impact factor: 9.890

66.Riva N, Di Minno MND, Mumoli N, Pomero F, Franchini M, Bellesini M, Lupoli R, Sabatini S, Borretta V, Bonfanti C, Ageno W, Dentali F. Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study. Haematologica. 2015;100:E295-E298. doi: 10.3324/haematol.2015.127183. Impact factor: 7.702

67.Pomero F, Di Minno MND, Premunian ET, Malato A, Pasca S, Barillari G, Fenoglio L, Siragusa S, Di Minno G, Ageno W, Dentali F. A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study. Thrombosis Research. 2015;136:938-942. doi: 10.1016/j.thromres.2015.09.010. Impact factor: 2.650

68.Dentali F, Pomero F, La Regina M, Orlandini F, Turato S, Mazzone A, Nozzoli C, Fontanella A, Ageno W, Agnelli G, Campanini M. Thromboprophylaxis in Acutely Ill Medical Patients: Results of A Survey Among Italian Physicians. Thrombosis Research. 2014;134:572-577. doi: 10.1016/j.thromres.2014.06.013. Impact factor: 2.650

69.Riva N, Bellesini M, Di Minno MND, Mumoli N, Pomero F, Franchini M, Fantoni C, Lupoli R, Brondi B, Borretta V, Bonfanti C, Ageno W, Dentali F. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism: A multicentre retrospective cohort study. Thrombosis and Haemostasis. 2014;112:511-521. doi: 10.1160/TH14-01-0081. Impact factor: 5.627

70.Pomero F, Ageno W, Serraino C, Borretta V, Gianni M, Fenoglio L, Prisco D, Dentali F. The role of inherited thrombophilia in patients with isolated pulmonary embolism: A systematic review and a meta-analysis of the literature. Thrombosis Research. 2014;134:84-89. doi: 10.1016/j.thromres.2014.04.012. Impact factor: 2.650

71.Dentali F, Pomero F, Annoni F, Giraudo AV, Maresca AM, Fenoglio L, Franchini M, Bono G. Role of ABO blood group as a prognostic factor in patients with spontaneous intracerebral hemorrhage. Journal of Thrombosis and Haemostasis. 2013;11:187-189. doi: 10.1111/jth.12057. Impact factor: 5.287

72.Fenoglio L, Serraino C, Castagna E, Cardellicchio A, Pomero F, Grosso M, Senore C. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases. World Journal of Gastroenterology. 2013;19:3207-3216. doi: 10.3748/wjg.v19.i21.3207. Impact factor: 3.800

73.Dentali F, Pomero F, Borretta V, Gianni M, Squizzato A, Fenoglio L, Ageno W, Prisco D. Location of venous thrombosis in patients with FVL or prothrombin G20210A mutations: Systematic review and meta-analysis. Thrombosis and Haemostasis. 2013;110:191-194. doi: 10.1160/TH13-02-0163. Impact factor: 5.627

74.Pomero F, Fenoglio L, Melchio R, Serraino C, Ageno W, Dentali F. Incidence and diagnosis of pulmonary embolism in Northern Italy: A population-based study. European Journal of Internal Medicine. 2013;24:E77-E78. doi: 10.1016/j.ejim.2013.01.007. Impact factor: 2.789

75.Pomero F, Melchio R, Sironi A, Giraudo AV, Dentali F, Fenoglio LM, Squizzato A. Short-term prognosis of intracranial haemorrhage in patients on oral anticoagulant or antiplatelet drugs. Thrombosis Research. 2013;132:765-769. doi: 10.1016/j.thromres.2013.10.004. Impact factor: 2.650

76.Pomero F, Dentali F, Borretta V, Bonzini M, Melchio R, Douketis JD, Fenoglio LM. Accuracy of emergency physician-performed ultrasonography in the diagnosis of deep-vein thrombosis: A systematic review and meta-analysis. Thrombosis and Haemostasis. 2013;109:137-145. doi: 10.1160/TH12-07-0473. Impact factor: 5.627

77.Pomero F, Brignone C, Serraino C, Panzone S, Bracco C, Migliore E, Dalmasso P, Perin PC, Fenoglio LM. Venous Lower-Limb Evaluation in Patients With Acute Pulmonary Embolism. Southern Medical Journal. 2011;104:405-411. doi: 10.1097/SMJ.0b013e318213d037. Impact factor: 0.850

78.Allione A, Melchio R, Martini G, Dutto L, Ricca M, Bernardi E, Pomero F, Menardo V, Tartaglino B. Factors influencing desired and received analgesia in emergency department. Internal and Emergency Medicine. 2011;6:69-78. doi: 10.1007/s11739-010-0463-9. Impact factor: 2.340

79.Bracco C, Melchio R, Sturlese U, Pomero F, Martini G, Poggi A, Cena P, Severini S, Castagna E, Brignone C, Serraino C, Dutto L, Veglio F, Fenoglio L. Early stratification of patients with chest pain and suspected acute coronary syndrome in the Emergency Department. Minerva Medica. 2010;101:73-80. ISSN: 0026-4806. Impact factor: 0.880

80.Dutto M, Pomero F, Migliore E, Fenoglio L. Cutaneous myiasis in a geriatric patient. Parassitologia. 2010;52:435-438. Impact factor: 1.200

81.Dutto L, Meineri P, Melchio R, Bracco C, Lauria G, Sciolla A, Pomero F, Sturlese U, Grasso E, Tartaglino B. Nontraumatic Headaches in the Emergency Department: Evaluation of a Clinical Pathway. Headache. 2009;49:1174-1185. doi: 10.1111/j.1526-4610.2009.01482.x. Impact factor: 2.961

82.Fenoglio LM, Severini S, Ferrigno D, Golle G, Serraino C, Bracco C, Castagna E, Brignone C, Pomero F, Migliore E, David E, Salizzoni M. Primary hepatic carcinoid: A case report and literature review. World Journal of Gastroenterology. 2009;15:2418-2422. doi: 10.3748/wjg.15.2418. Impact factor: 3.800

83.Migliore E, Serraino C, Brignone C, Ferrigno D, Cardellicchio A, Pomero F, Castagna E, Osenda M, Fenoglio L. Pasteurella multocida infection in a cirrhotic patient: case report, microbiological aspects and a review of literature. Advances in Medical Sciences. 2009;54:109-112. doi: 10.2478/v10039-009-0005-8. Impact factor: 1.364

84.Dutto L, Pomero F, Allione A. Multiple abscesses in brucellosis with Wright’s test negativity. BMJ Case Reports. 2009. pii: bcr06.2008.0243. doi: 10.1136/bcr.06.2008.0243. Impact factor: 0.320

85.Fenoglio L, Cena P, Migliore E, Bracco C, Ferrigno D, Silvestri A, Lingua G, Golle G, Brignone C, Serraino C, Gallarato G, Pomero F, Grosso M. Vertebroplasty in the treatment of osteoporosis vertebral fractures: Report on 52 cases. Journal of Endocrinological Investigation. 2008;31:795-798. doi: 10.1007/BF03349260. Impact factor: 2.633

86.Fenoglio L, Cena P, Bracco C, Pomero F, Migliore E, Benedetti V, Morino M, Perin PC. Proximalisation of colorectal carcinoma: A 10-year study in Italy. Digestive Diseases and Sciences. 2008;53:736-740. doi: 10.1007/s10620-007-9916-z. Impact factor: 2.875

87.Fenoglio L, Allione A, Scalabrino E, Alberto G, Benedetti V, Pomero F, Valpreda S, Morino M, Perin PC. Spontaneous dissection of the celiac artery: a pitfall in the diagnosis of acute abdominal pain. Presentation of two cases. Digestive Diseases and Sciences. 2004;49:1223-1227. Impact factor: 2.875

88.Allione A, Montanaro M, Marmont F, Pomero F, Porta M. Fungal endophthalmitis in acute leukaemia. British Journal of Haematology. 2004;124:257. Impact factor: 5.670

89.Allione A, Pomero F, Valpreda S, Porta M, Mallone R, Rabbia C, Cavallo Perin P. Worsening of hypertension in a pregnant woman with renal arteriovenous malformation: a successful superselective embolization after delivery. Clinical Nephrology. 2003;60:211-213. Impact factor: 1.660

90.Pomero F, Allione A, Beltramo E, Buttiglieri S, D’Alù F, Ponte E, Lacaria A, Porta M (2003). Effects of protein kinase C inhibition and activation on proliferation and apoptosis of bovine retinal pericytes. Diabetologia. 46:416-419. Impact factor: 6.080.

91.Beltramo E, Buttiglieri S, Pomero F, Allione A, D’Alù F, Ponte E, Porta M (2003). A study of capillary pericyte viability on extracellular matrix produced by endothelial cells in high glucose. Diabetologia. 46:409-415. Impact factor: 6.080..

92.Limone P, Berardi C, Pomero F, Del Rizzo P, Allione A, Beltramo E, D’Alù F, Ponte E, Pellissetto C, Lacaria A, Barberis AM, Porta M (2002). Failure of angiotensin II and insulin to stimulate transforming growth factor-beta1 release from cultured bovine retinal pericytes. Diabetes Metab. 28:499-503. Impact factor: 4.101.

93.Beltramo E, Pomero F, Allione A, D’Alù F, Ponte E, Porta M (2002). Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia. 45:416-419. Impact factor: 6.080.

94.Pomero F, Molinar Min A, La Selva M, Allione A, Molinatti GM, Porta M (2001). Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose. Acta Diabetol. 38:135-138. Impact factor: 3.340.

95.Trento M, Passera P, Tomalino M, Bajardi M, Pomero F, Allione A, Vaccari P, Molinatti GM, Porta M (2001). Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up. Diabetes Care. 24:995-1000. Impact factor: 11.857.

96.Pomero F, Allione A, Molinar Min A, La Selva M, Porta M (2000). Thiamine, beta-cell function and peripheral glucose utilization in thiamine-responsive megaloblastic anemia (TRMA) syndrome. Acta Diabetol. 37:103. Impact factor: 3.340.

97.Porta M, Rizzitiello A, Tomalino M, Trento M, Passera P, Minonne A, Pomero F, Gamba S, Castellazzi R, Montanaro M, Sivieri R, Orsi R, Bondonio P, Molinatti GM (1999). Comparison of the cost-effectiveness of three approaches to screening for and treating sight-threatening diabetic retinopathy. Diabetes Metab. 25:44-53. Impact factor: 4.101.

PRODUZIONEDI CAPITOLI DI LIBRI:

–        Autore del capitolo “Antiaggreganti eAnticoagulanti” nel testo FARMACOLOGIA CLINICA & TERAPIA SISTEMATICA-Idelson Gnocchi. 

REVIEWER PER LE SEGUENTI RIVISTE SCIENTIFICHE INTERNAZIONALI:

 CHEST –I.F. 6.147

Thrombosis and Haemostasis – I.F. 5.627
Journal of Thrombosis and Haemostasis – I.F. 5.287
European Journal of Internal Medicine – I.F. 3.660
PLOS ONE – I.F. 3.540
Heart and Vessel – I.F. 3.434
Acta Diabetologica – I.F. 3.340
Pharmacoepidemiology and Drug Safety – I.F. 2.908
Journal of Diabetes and its Complications – I.F. 2.734
Thrombosis Research – I.F. 2.650
BioMed Research International – I.F. 2.583
Journal of Infection and Public Health – I.F. 2.487
GENE – I.F. 2.415
BMJ Open – I.F. 2.369
Internal and Emergency Medicine – I.F. 2.340
Journal of Thrombosis and Thrombolysis – I.F. 2.142
Clinical and Applied Thrombosis/Haemostasis – I.F. 2.096
Nutrition Research – I.F. 2.039
Oncology – I.F. —
BMC Hematology – I.F. —

– Autore di più di120  abstract presentati a congressi nazionali ed internazionali

– Relatore a più di 150 tra corsi e Congressi Nazionali ed internazionali